Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-06-04

Reporting Person: Brosgart Carol L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-04	Stock Option (right to buy)	$16.88	A	34000	Acquired	2031-06-03	Common Stock (34000)	Direct

Footnotes

F1: The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant.